-
Drugmakers, hospitals, clinics and policymakers have argued for years over a program known as 340B.
-
The manufacturer of a drug linked to Indiana's 2015 HIV outbreak spent more than $200,000 in 2016 promoting its opioid-based pain medication to…
-
The Auvi-Q epinephrine injector was pulled from the market in 2015 because of quality concerns. Now, the drug's maker says the problems have been solved and Auvi-Q will be available again in 2017.
-
The American College of Physicians will lobby Congress to allow the re-importation of medicines from other countries and to let Medicare bargain with drugmakers over price. Will lawmakers go along?
-
Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs.There’s been…
-
The U.S. is one of only two countries in the world that allow prescription drug companies to advertise directly to consumers. In a statement issued…
-
Believe it or not, it may be cheaper to pay for a prescription yourself rather than using your insurance. And if that fails, there are other places to turn for help getting the best possible deal.
-
More than a hundred influential doctors banded together to propose seven ways to bring down the high prices of cancer drugs. They say changes are needed to preserve access to care.
-
As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the…